Jindal Piyush 4
4 · LifeMD, Inc. · Filed Nov 8, 2023
Insider Transaction Report
Form 4
LifeMD, Inc.LFMD
Jindal Piyush
Director
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2023-11-06−37,500→ 0 totalExercise: $2.52→ Common Stock (37,500 underlying) - Exercise/Conversion
Common Stock
2023-11-06$2.52/sh+37,500$94,500→ 337,500 total
Footnotes (1)
- [F1]The options vested in four equal installments at 90, 180, 270 and 365 days from September 14, 2022, the date of grant. The option expires on September 14, 2027.